- Home
- CLMT
as of 03-23-2026 3:52pm EST
$27.99
+$0.11
+0.39%
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
| Founded: | 1916 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 2.1B | IPO Year: | 2024 |
| Target Price: | $23.25 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | 85.39 |
| 52 Week Low/High: | $7.68 - $31.41 | Next Earning Date: | 05-08-2026 |
| Revenue: | $4,137,100,000 | Revenue Growth: | -1.25% |
| Revenue Growth (this year): | 4.45% | Revenue Growth (next year): | -2.04% |
| P/E Ratio: | -71.49 | Index: | N/A |
| Free Cash Flow: | 56.6M | FCF Growth: | N/A |
AI-Powered CLMT Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 21 hours ago
AI Recommendation
hold
Model Accuracy: 77.30%
77.30%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 27, 2026 · 97% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 27, 2026 · 97% conf.
AI Prediction BUY
1D
+4.24%
$27.85
Act: +2.58%
5D
+12.96%
$30.18
Act: +13.01%
20D
+25.11%
$33.43
Price: $26.72 Prob +5D: 98% AUC: 1.000
0002013745-26-000003
Calumet, Inc. /DE_February 27, 2026 Calumet, Inc. /DE0002013745false00020137452026-02-272026-02-27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2026
CALUMET, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-42172 36-5098520
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
1060 N Capitol Ave Suite 6-401 Indianapolis, Indiana 46204 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code (317) 328-5660 (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share
CLMT
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 27, 2026, Calumet, Inc. reported results of operations for the quarter and year ended December 31, 2025, pursuant to a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information contained in this report shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description
99.1 Press release dated February 27, 2026.
104 Cover Page Interactive Data File- the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CALUMET, INC.
February 27, 2026 By: /s/ David Lunin
Name: David Lunin
Title: Executive Vice President and Chief Financial Officer
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 6, 2026 · 97% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 6, 2026 · 97% conf.
AI Prediction BUY
1D
+4.24%
$27.85
Act: +2.58%
5D
+12.96%
$30.18
Act: +13.01%
20D
+25.11%
$33.43
Price: $26.72 Prob +5D: 98% AUC: 1.000
0001193125-26-003207
8-K
Calumet, Inc. /DE false 0002013745 0002013745 2026-01-05 2026-01-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2026
CALUMET, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-42172
36-5098520
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1060 N Capitol Ave Suite 6-401 Indianapolis, Indiana 46204 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code (317) 328-5660
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
CLMT
The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On January 5, 2026, Calumet, Inc. (the “Company”) issued a press release announcing preliminary unaudited information related to the Company’s liquidity and select fiscal year 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and Exhibit 99.1 be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Exhibit Title or Description
99.1
Press Release, dated January 5, 2026, announcing preliminary unaudited information.
104
Cover Page Interactive Data File- the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CALUMET, INC.
Date: January 5, 2026
By:
/s/ David Lunin
Name:
David Lunin
Title:
Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 7, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 7, 2025
0002013745-25-000017
Calumet, Inc. /DE_November 7, 2025 Calumet, Inc. /DE0002013745false00020137452025-11-072025-11-07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2025
CALUMET, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-42172
36-5098520
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
1060 N Capitol Ave Suite 6-401 Indianapolis, Indiana 46204 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code (317) 328-5660 (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
CLMT
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On November 7, 2025, Calumet, Inc. reported results of operations for the quarter ended September 30, 2025, pursuant to a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information contained in this report shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No.
Description
99.1 Press release dated November 7, 2025.
104 Cover Page Interactive Data File- the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CALUMET, INC.
November 7, 2025 By: /s/ David Lunin
Name: David Lunin
Title: Executive Vice President and Chief Financial Officer
Latest Calumet Specialty Products Partners L.P. News
CLMT Breaking Stock News: Dive into CLMT Ticker-Specific Updates for Smart Investing
PR Newswire
Calumet to Attend H.C. Wainwright Renewable Fuels Virtual Day
📊
AI Sentiment
Positive
6/10
PR Newswire
Calumet Completes Offering of $150 Million of Additional 9.75% Senior Notes due 2031
📈
AI Sentiment
Highly Positive
8/10
Compare CLMT vs Leading Stocks
See how CLMT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CLMT Calumet Specialty Products Partners L.P. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.